Your browser doesn't support javascript.
loading
Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo.
Flamiatos, Jason F; Beer, Tomasz M; Graff, Julie N; Eilers, Kristine M; Tian, Wei; Sekhon, Harman S; Garzotto, Mark.
  • Flamiatos JF; School of Medicine, School of Public Health, Oregon Health and Science University, Portland, OR, USA.
  • Beer TM; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Graff JN; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Eilers KM; Hospital and Specialty Medicine, VA Portland Health Care System, Portland, OR, USA.
  • Tian W; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Sekhon HS; Miraca Life Sciences, Irving, TX, USA.
  • Garzotto M; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada.
BJU Int ; 119(5): 709-716, 2017 05.
Article en En | MEDLINE | ID: mdl-27480340
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Inhibidores de la Ciclooxigenasa 2 / Celecoxib Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Inhibidores de la Ciclooxigenasa 2 / Celecoxib Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article